Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30, 2026 and inter alia to pass other business agenda''s

Mangalam Drugs and Organics Limited MANGAL Regd: Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. 0. Mumbai - 400 001 @ 91-22-62616200 / 63/0 87087 @ 91-22-62619090 e CIN L24230MH1972PLC116413 WH AcO cr- ediG teM dP REF: MDOL/CS-SE/2026-27/038 October 29", 2026 Listing Department Listing Department BSE Ltd National Stock Exchange of India 1* Floor, New Trade Wing, Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, 5" Floor, Dalal Street, Fort, Plot No. C-1, Block G, Mumbai - 400 001 Bandra - Kurla Complex, Bandra(E), Mumbai — 400 051 Scrip Code: 532637 Symbol: MANGALAM Subject: Mangalam Drugs and Organics Limited “the Company”- Prior Intimation of Board Meeting to be held on Thursday, November 5, 2026 Dear Sir/Madam, Pursuant to Regulation 29 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 5" , 2026 at the registered office of the Company situated at 3" Floor, Rupam Building, 2 bu3 s9 i, P e. sD e’ sM ee nl ul no iR ao ta ed d, aN se ua nr eG r. :P .O., Mumbai, Maharashtra-400001 inter-alia to consider the following 0I) To consider, approve and take on record the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended September 30, 2026 (“the Financial Results™); Further, in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) tR re ag du il na gt ,i o thn es , r2 a0 d15 i, ga Wnd a oc wc o fr od ra dn ec ae iw ni gt h nC to hm ep sa en cy ur’ is i en st oer fn ta hl c Cod oe o pf c no yn d hu asc t efo er p cr le ov se en dt i fo on o Dif i en cs ti od re sr / Officers and designated employees of the Company from October 1, 2026 and shall remain closed till the expiry of 48 hours from the announcement / declaration of the Un-audited Financial Results of the Company for the quarter ended September 30, 2026, The closure of Trading Window has been informed to the Designated Persons covered by the Code. Kindly take the above information on your records. Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.mangalamdrugs.com